AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
What Lilly’s AI Deal Means Now: Drug Discovery Is Entering a Scale Test, Not a Concept Test
PharmTech’s analysis of Lilly’s latest AI drug discovery move points to a more mature phase for the sector, where the central question is no longer whether AI can help discover compounds, but whether it can do so repeatedly at portfolio scale. The next proving ground will be translation into clinically and commercially meaningful assets.
BioPharma Dive: Lilly’s AI Expansion Shows Big Pharma Is Building a Portfolio, Not Picking a Winner
BioPharma Dive’s coverage of Lilly’s expanded work with Insilico points to a broader strategic pattern: large pharmaceutical companies are constructing diversified AI discovery portfolios rather than betting on a single platform. That approach mirrors how pharma manages scientific risk in every other part of R&D.
GEN: Lilly’s Expanded AI Footprint Shows Big Pharma Is Building Discovery Capacity Through Portfolios, Not Bets
Genetic Engineering & Biotechnology News frames Lilly’s latest collaboration as part of a broader expansion of its AI footprint. The significance is strategic: large pharma increasingly appears to be treating AI partnerships as a portfolio-building exercise across modalities and programs, rather than as isolated moonshots.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.